Treatment of the blood cancer polycythemia vera with ruxolitinib in the MAJIC-PV study: a plain language summary

Gerne weisen wir Sie auf eine englischsprachige Studie hin. Die gesamten Resultate sehen Sie, wenn Sie die PDF-Datei öffen (View PDF).

The study focused on patients with PV who were either intolerant or resistant to hydroxycarbamide (hydroxyurea).

We are pleased to share with you the recently published plain language summary of the MAJIC PV study, which provides valuable insights into the treatment of polycythemia vera (PV) using Ruxolitinib.

The study focused on patients with PV who were either intolerant or resistant to hydroxycarbamide (hydroxyurea).